Eramol was created by Eric Che and Peter Mollison.
Eric and Peter embrace challenges with an inspired and forward-thinking approach. Eramol was founded on the shared values of the co-founders to offer a tailored and responsive clinical trial manufacturing services to sponsors with a wide set of requirements.
Eric has worked in the pharmaceutical sector for over 15 years, since completing his pharmacist training in the NHS. He is an eligible EU Qualified Person, responsible for supply chain audit oversight and batch release for clinical and commercial products. Eric has worked with a broad range of sterile and non-sterile dosage forms including orphan products as well as time critical sterile and veterinary products. He holds leadership roles in quality, delivering a green field manufacturing facility design project, GMP licence applications and building brand-new quality teams.
CEO & Co-Founder
Peter has over 15 years’ experience in the pharmaceutical industry. Qualifying as a pharmacist in 2004, he worked at the Institute of Cancer Research on pharmacogenomic and drug discovery, before moving into commercial and clinical sterile and non-sterile production roles in the UK NHS and commercial organisations. Since 2009, he has worked in Quality roles covering dosage forms, including radiopharmaceuticals and ATMPs. Gaining QP status in 2014, Peter performed batch release for large and small-scale pharmaceutical EU organisations, before continuing as a consultant, overseeing projects including facility builds, FDA remediation, training and QMS implementation.
CEO & Co-Founder
Dave has a first class honours degree in Management Banking and Finance and over 21 years banking experience. He specialises in risk management and is a specialist member of the Institute of Risk Management with strong compliance and corporate governance experience. Dave is a Chief Risk Officer and Money Laundering Reporting Officer. Dave independently challenges and supports our business operations to ensure we maintain effective systems and controls. Dave also brings a strong community focus to our business along with a focus on strategy, culture and people, ensuring we attract, retain and develop our talented people.
Senior Advisor to Directors
Royford is a dual qualified (UK/Hong Kong) lawyer with over 20 years of commercial and corporate legal experience. He is tri-lingual, entrepreneurial and globally experienced. He was the Corporate Counsel and head of international commercial legal team of Alibaba Group and the General Counsel of 51 Group (which is a UK and China e-commerce and logistics services provider). Royford doesn;t only have substantial legal experience, and was a member of the senior management and corporate strategy team team of his former employer.
Eramol has developed a profound customer process that aims to deliver complete satisfaction to our clients at every stage.
The company is privately owned. As a private equity-free company, Eramol is able to act in the best interests of the Company and its Clients, with a focus on service, delivery and innovation.
Eramol is an authorised organisation across many strategic areas of the business. Accreditations relate to MHRA, HPRA, MHRA GDP and WDA(v). We work with all relevant bodies to ensure the very latest accreditations in line with ongoing, continuous developments in the industry.